Evidence map›Paper›PMID 21965015›Full record

ArticleAmerican journal of respiratory and critical care medicine2011

Oxidative stress-induced antibodies to carbonyl-modified protein correlate with severity of chronic obstructive pulmonary disease.

Paul A Kirkham, Gaetano Caramori, Paolo Casolari, Alberto A Papi, Matt Edwards, Betty Shamji, Kostas Triantaphyllopoulos, Farhana Hussain, Mariona Pinart, Younis Khan and 6 more

Abstract read
In one paragraph

Article in American journal of respiratory and critical care medicine, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 86 papers.

0numbers the graph read from it
0cells of the map it votes in
86citing papers in PubMed
12.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

86 citing papers in PubMed, 182 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Review
  5. Review
  6. Mechanisms and markers of lung ageing in health and disease.European respiratory review : an official journal of the European Respiratory Society · 2025
    Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. The persistent inflammation in COPD: is autoimmunity the core mechanism?European respiratory review : an official journal of the European Respiratory Society · 2024
    Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article

26 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors at 4 institutions in 2 countries.

Paul A KirkhamNational Heart and Lung Institute, Imperial College London, Dovehouse Street, London SW3 6LY UK. p.kirkham@imperial.ac.uk
Gaetano Caramori
Paolo Casolari
Alberto A Papi
Matt Edwards
Betty Shamji
Kostas Triantaphyllopoulos
Farhana Hussain
Mariona Pinart
Younis Khan
Lucy Heinemann
Laurie Stevens
Mike Yeadon
Peter J Barnes
Kian F Chung
Ian M Adcock
Imperial College London · GBUniversity of Ferrara · ITNovartis (United Kingdom) · GBNIHR Imperial Biomedical Research Centre · GB

Funding

Medical Research Council G1000758Wellcome Trust
6 · The paper itself

Abstract

rationaleThere is increasing evidence for the presence of autoantibodies in chronic obstructive pulmonary disease (COPD). Chronic oxidative stress is an essential component in COPD pathogenesis and can lead to increased levels of highly reactive carbonyls in the lung, which could result in the formation of highly immunogenic carbonyl adducts on "self" proteins.

objectivesTo determine the presence of autoantibodies to carbonyl-modified protein in patients with COPD and in a murine model of chronic ozone exposure. To assess the extent of activated immune responses toward carbonyl-modified proteins.

methodsBlood and peripheral lung were taken from patients with COPD, age-matched smokers, and nonsmokers with normal lung function, as well as patients with severe persistent asthma. Mice were exposed to ambient air or ozone for 6 weeks. Antibody titers were measured by ELISA, activated compliment deposition by immunohistochemistry, and cellular activation by ELISA and fluorescence-activated cell sorter. MEASUREMENTS AND MAIN

resultsAntibody titer against carbonyl-modified self-protein was significantly increased in patients with Global Initiative for Chronic Obstructive Lung Disease stage III COPD compared with control subjects. Antibody levels inversely correlated with disease severity and showed a prevalence toward an IgG1 isotype. Deposition of activated complement in the vessels of COPD lung as well as autoantibodies against endothelial cells were also observed. Ozone-exposed mice similarly exhibited increased antibody titers to carbonyl-modified protein, as well as activated antigen-presenting cells in lung tissue and splenocytes sensitized to activation by carbonyl-modified protein.

conclusionsCarbonyl-modified proteins, arising as a result of oxidative stress, promote antibody production, providing a link by which oxidative stress could drive an autoimmune response in COPD.

Indexed as

AgedAnimalsAsthmaAutoantibodiesCase-Control StudiesFemaleHumansMaleMatched-Pair AnalysisMiceMice, Inbred BALB CMiddle AgedOxidative StressOzoneProtein CarbonylationPulmonary Disease, Chronic ObstructiveAutoantibodiesOzone

Identifiers

PMID21965015
PMCPMC3398415
OpenAlexW2087861952

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.